Gala Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

Gala Therapeutics General Information

Description

Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with lung cancer, COPD (Chronic Obstructive Pulmonary Disease), asthma, and other pulmonary diseases. The company's platform offers a single-use catheter and electrosurgical generator to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients, enabling physicians to treat their patients better, resulting in a better medical outcome.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Parent Company
Corporate Office
  • 1531 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gala Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-Sep-2022 000.00 Completed Generating Revenue
2. Later Stage VC 22-Mar-2022 000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Nov-2019 $42.5M $42.5M 000.00 Completed Generating Revenue
To view Gala Therapeutics’s complete valuation and funding history, request access »

Gala Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view Gala Therapeutics’s complete cap table history, request access »

Gala Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with l
Therapeutic Devices
San Carlos, CA
24 As of 2023
000.00
000000&0 000.00

000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
00000000000 0000000
Lexington, MA
00 As of 0000
00000
0000000000 0 00000

000000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut la
00000000 0000000
Maple Grove, MN
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gala Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RejuvenAir Venture Capital-Backed Lexington, MA 00 00000 0000000000 0 00000
Nuvaira Venture Capital-Backed Maple Grove, MN 00 00000 0000000000 0 00000
Pulmonx Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Gala Therapeutics Executive Team (3)

Name Title Board Seat
Kevin Taylor Chief Operating Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Gala Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gala Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apple Tree Partners (ATP) Venture Capital Minority 000 0000 000000 0
To view Gala Therapeutics’s complete investors history, request access »

Gala Therapeutics FAQs

  • When was Gala Therapeutics founded?

    Gala Therapeutics was founded in 2015.

  • Who is the founder of Gala Therapeutics?

    Jonathan Waldstreicher MD is the founder of Gala Therapeutics.

  • Where is Gala Therapeutics headquartered?

    Gala Therapeutics is headquartered in San Carlos, CA.

  • What is the size of Gala Therapeutics?

    Gala Therapeutics has 24 total employees.

  • What industry is Gala Therapeutics in?

    Gala Therapeutics’s primary industry is Therapeutic Devices.

  • Is Gala Therapeutics a private or public company?

    Gala Therapeutics is a Private company.

  • What is Gala Therapeutics’s current revenue?

    The current revenue for Gala Therapeutics is 000000.

  • How much funding has Gala Therapeutics raised over time?

    Gala Therapeutics has raised $48.5M.

  • Who are Gala Therapeutics’s investors?

    Apple Tree Partners (ATP) has invested in Gala Therapeutics.

  • Who are Gala Therapeutics’s competitors?

    RejuvenAir, Nuvaira, and Pulmonx are competitors of Gala Therapeutics.

  • When was Gala Therapeutics acquired?

    Gala Therapeutics was acquired on 15-Sep-2022.

  • Who acquired Gala Therapeutics?

    Gala Therapeutics was acquired by Galvanize Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »